A new vaccine adjuvant (BOS 2000) a potent enhancer mixed Th1/Th2 immune responses in mice immunized with HBsAg

Vaccine

Volumn 25, Issue 23, 2007, Pages 4586-4594

  Khajuria, Anamika ^a   Gupta, Amit ^a   Malik, Fayaz ^a   Singh, Surjeet ^a   Singh, Jaswant ^a   Gupta, B D ^a   Suri, K A ^a   Suden, Pankaj ^a   Srinivas, V K ^b   Ella, Krishna ^b   Qazi, G N ^a  

^a CSIR INDIAN INSTITUTE OF INTEGRATIVE MEDICINE   (India)

^b Bharat Biotech International Limited   (India)

Author keywords

Boswellia serrata; Hepatitis B (HBsAg) surface antigen; Humoral and cellular

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; ADJUVANT; ALUMINUM POTASSIUM SULFATE; BOS 2000; BOSWELLIA SERRATA EXTRACT; GAMMA INTERFERON; HEPATITIS B SURFACE ANTIGEN; IMMUNOGLOBULIN G1 ANTIBODY; IMMUNOGLOBULIN G2A ANTIBODY; INTERLEUKIN 4; NEUTRALIZING ANTIBODY; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY TITER; ANTIGEN SPECIFICITY; ARTICLE; BOSWELLIA; BOSWELLIA SERRATA; CD4 CD8 RATIO; CELL VIABILITY; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOKINE PRODUCTION; DOSE RESPONSE; DRUG DOSE REDUCTION; DRUG MECHANISM; DRUG POTENCY; DRUG SCREENING; FLOW CYTOMETRY; IMMUNE RESPONSE; IMMUNIZATION; LYMPHOCYTE PROLIFERATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN LYMPHOCYTE; TH1 CELL; TH2 CELL;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; BOSWELLIA; FLOW CYTOMETRY; HEPATITIS B ANTIBODIES; HEPATITIS B SURFACE ANTIGENS; IMMUNIZATION; IMMUNOGLOBULIN G; INTERLEUKIN-4; MALE; MICE; MICE, INBRED BALB C; TH1 CELLS; TH2 CELLS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 34248570548     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2007.03.051     Document Type: Article

References (23)

1. Freitas EO, Casas CP, Borja-Cabrera GP, Santos FN, Nico D, Souza LOP, et al. Acylated and deacylated saponins of Quillaja saponaria mixture as adjuvants for the FML-vaccine against visceral leishmaniasis. Vaccine; 24:3909-20.
2. Khajuria A, Gupta A, Singh S, Malik F, Singh J, Suri KA, et al. RLJ-NE-299A: a new plant based vaccine adjuvant. Vaccine; in press.
3. Petrovsky N. Novel human polysaccharide adjuvants with dual Th1 and Th2 potentiating activity. Vaccine 24 (2006) S26-S29
4. Allison A.C., and Byars N.E. Immunological adjuvants: desirable properties and side effects. Mol Immunol 28 (1991) 279-284
5. Edelman R. The development and use of vaccine adjuvants. Mol Biotechnol 21 (2002) 56-67
6. Edelman R. Vaccine adjuvants. Rev Infect Dis 2 (1980) 370-383
7. Banerjee SK, Suri OP, Taneja SC, Gupta BD, Sethi VK, Anand AS, et al. Water-soluble bioactive fraction process for there of from gum resin extract of Boswellia serrata composition containing said bioactive frication and method for the treatment of arthritis using said fraction. Patent filed in US.
8. Singh G.B., Singh S., and Bani S. Boswellic-acids-anti-inflammatory, anti-arthritic, anti-pyretic. Drugs Future 18 (1993) 307-309
9. Singh G.B., Singh S., and Bani S. Anti-inflammatory actions of Boswellic acids. Phytomedicine 3 1 (1996) 81-85
10. Singh G.B., and Atal C.K. Pharmacology of an extract of salai guggal ex- Boswellia serrata, a new non-steroidal anti-inflammatory agent. Agents Actions 18 (1986) 3-4
11. Sharma M.L., Kaul A., Khajuria A., Singh S., and Singh G.B. Immunomodulatory activity of Boswellic acids (Pentacyclic Triterpene Acids) from Boswellia serrata. Phytother Res 10 (1996) 107-112
12. Hostanska K., Daum G., and Saller R. Cytostatic and apoptosis-inducing activity of boswellic acids toward malignant cell lines in vitro. Anti-cancer Res 22 5 (2002) 2853-2862
13. Liu J.J., Nilsson A., Oredsson S., Badmaev V., Zhao W.Z., and Duan R.D. Boswellic acids trigger apoptosis via a pathway dependent on caspase-8 activation but independent on Fas/Fas ligand interaction in colon cancer HT-29 cells. Carcinogenesis 23 12 (2002) 2087-2093
14. Liu J.J., Nilsson A., Oredsson S., Badmaev V., and Duan R.D. Keto- and acetyl-keto-boswellic acids inhibit proliferation and induce apoptosis in Hep G2 cells via a caspase-8 dependent pathway. Int J Mol Med 10 4 (2002) 501-505
15. Xu H., Yunyi Z., Jianwen Z., and Daofeng C. Isolation and characterization of an anti-complementary polysaccharide D3-S1 from the roots of Bupleurum smithii. Int Immunopharmacol 7 2 (2007) 175-182
16. Sun-A I., Kyungjae K., and Chong-Kil L. Immunomodulatory activity of polysaccharides isolated from Salicornia herbacea. Int Immunopharmacol 6 9 (2006) 1451-1458
17. Liu C., Leung M.Y.K., Koon J.C.M., Zhu L.F., Hui Y.Z., Yu B., et al. Macrophage activation by polysaccharide biological response modifier isolated from Aloe vera L. var. chinensis (Haw.) Berg. Int Immunopharmacol 6 11 (2006) 1634-1641
18. Wang Y.P., and Li X.Y. Effect of astragaloside IV on T, B lymphocyte proliferation and peritoneal macrophage function in mice. Acta Pharmacol Sin 3 (2002) 263-266
19. Schreiber R.D., Aguet M., and Nicola N.A. Guidebook to cytokines and their receptors (1994), Oxford University Press, New York p. 120
20. Aggarwal B.B., and Vilcek J. Tumor necrosis factor: structure, function and mechanism of action (1991), Marcel Dekker Inc., New York
21. Assenmacher M., Schmitz J., and Radbruch A. Flow cytometric determination of cytokines in activated murine T helper lymphocytes: expression of interleukin-10 in interferon-gamma and in interleukin-4-expressing cells. Eur J Immunol 24 (1994) 1097-1101
22. Roger P.M. Revival of the regulatory T cell: new targets for drug development. Drug Discov Today 9 (2004) 310-316
23. Mosmann T.R., and Coffman R.L. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 7 (1989) 145